Pembrolizumab,Vibostolimab,Favezelimab
merck
['mibc', 'pembro', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'bladder']
pembrolizumab demonstrates antitumor activity in bcg-unresponsive papillary nmibc #urology #urologist #bladdercancer #gu23 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.